DAG Ventures Management III, LLC - Net Worth and Insider Trading
DAG Ventures Management III, LLC Net Worth
The estimated net worth of DAG Ventures Management III, LLC is at least $7 Million dollars as of 2025-05-12. DAG Ventures Management III, LLC is the 10% Owner of Adamas Pharmaceuticals Inc and owns about 889,606 shares of Adamas Pharmaceuticals Inc (ADMS) stock worth over $7 Million. Details can be seen in DAG Ventures Management III, LLC's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that DAG Ventures Management III, LLC has not made any transactions after 2014-04-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of DAG Ventures Management III, LLC
DAG Ventures Management III, LLC Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, DAG Ventures Management III, LLC owns 2 companies in total, including Adamas Pharmaceuticals Inc (ADMS) , and YuMe Inc (YUME) .
Insider Ownership Summary of DAG Ventures Management III, LLC
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2014-04-15 | 10 percent owner |
| YUME | YuMe Inc | 2014-03-07 | 10 percent owner |
DAG Ventures Management III, LLC Latest Holdings Summary
DAG Ventures Management III, LLC currently owns a total of 1 stock. DAG Ventures Management III, LLC owns 889,606 shares of Adamas Pharmaceuticals Inc (ADMS) as of April 9, 2014, with a value of $7 Million.
Latest Holdings of DAG Ventures Management III, LLC
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2014-04-09 | 889,606 | 8.22 | 7,312,561 |
Holding Weightings of DAG Ventures Management III, LLC
DAG Ventures Management III, LLC Form 4 Trading Tracker
According to the SEC Form 4 filings, DAG Ventures Management III, LLC has made a total of 0 transactions in Adamas Pharmaceuticals Inc (ADMS) over the past 5 years. The most-recent trade in Adamas Pharmaceuticals Inc is the sale of 0 shares on April 9, 2014, which brought DAG Ventures Management III, LLC around $0.
Insider Trading History of DAG Ventures Management III, LLC
- 1
DAG Ventures Management III, LLC Trading Performance
DAG Ventures Management III, LLC Ownership Network
Ownership Network List of DAG Ventures Management III, LLC
Ownership Network Relation of DAG Ventures Management III, LLC
DAG Ventures Management III, LLC Owned Company Details
What does Adamas Pharmaceuticals Inc do?
Who are the key executives at Adamas Pharmaceuticals Inc?
DAG Ventures Management III, LLC is the 10 percent owner of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .
Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adamas Pharmaceuticals Inc Insider Transactions
DAG Ventures Management III, LLC Mailing Address
Above is the net worth, insider trading, and ownership report for DAG Ventures Management III, LLC. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, DAG Ventures Management III, LLC's mailing address is: Suite 200 Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
